# Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19)

> **NCT04408170** · — · COMPLETED · sponsor: **Manchester University NHS Foundation Trust** · enrollment: 8380 (actual)

## Conditions studied

- Coronavirus Infection
- COVID-19

## Interventions

- **DIAGNOSTIC_TEST:** Point-of-care test for SARS-CoV-2

## Key facts

- **NCT ID:** NCT04408170
- **Lead sponsor:** Manchester University NHS Foundation Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-19
- **Primary completion:** 2021-01-26
- **Final completion:** 2024-12-01
- **Target enrollment:** 8380 (ACTUAL)
- **Last updated:** 2025-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04408170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04408170, "Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04408170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
